These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26152979)

  • 1. eHealth Services for the European Reference Network on Rare Anaemias (eENERCA).
    Antoniou Z; Schiza EC; Neokleous K; Angastiniotis M; Pattichis CS; Schizas CN
    Stud Health Technol Inform; 2015; 213():153-6. PubMed ID: 26152979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sustainable solution for the activities of the European network for surveillance of congenital anomalies: EUROCAT as part of the EU Platform on Rare Diseases Registration.
    Kinsner-Ovaskainen A; Lanzoni M; Garne E; Loane M; Morris J; Neville A; Nicholl C; Rankin J; Rissmann A; Tucker D; Martin S
    Eur J Med Genet; 2018 Sep; 61(9):513-517. PubMed ID: 29597096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of rare anaemias in Europe.
    Gulbis B; Eleftheriou A; Angastiniotis M; Ball S; Surrallés J; Castella M; Heimpel H; Hill A; Corrons JL
    Adv Exp Med Biol; 2010; 686():375-96. PubMed ID: 20824457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention, diagnosis and services.
    Bermejo E; Martínez-Frías ML
    Adv Exp Med Biol; 2010; 686():55-75. PubMed ID: 20824439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare Disease Biospecimens and Patient Registries: Interoperability for Research Promotion, a European Example: EuroBioBank and SpainRDR-BioNER.
    Rubinstein YR; Posada de la Paz M; Mora M
    Adv Exp Med Biol; 2017; 1031():141-147. PubMed ID: 29214569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current situation and needs of rare disease registries in Europe.
    Taruscio D; Gainotti S; Mollo E; Vittozzi L; Bianchi F; Ensini M; Posada M
    Public Health Genomics; 2013; 16(6):288-98. PubMed ID: 24503589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Registries for rare diseases : OSSE - An open-source framework for technical implementation].
    Storf H; Schaaf J; Kadioglu D; Göbel J; Wagner TOF; Ückert F
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 May; 60(5):523-531. PubMed ID: 28289778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Public health research on rare diseases.
    Alonso V; Villaverde-Hueso A; Hens M; Morales-Piga A; Abaitua I; Posada de la Paz M
    Georgian Med News; 2011 Apr; (193):11-6. PubMed ID: 21617266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rare diseases. A national network to benefit early diagnosis and more effective therapies].
    Taruscio D; Kodra Y
    Epidemiol Prev; 2011; 35(5-6 Suppl 2):92-3. PubMed ID: 22166875
    [No Abstract]   [Full Text] [Related]  

  • 10. Supporting international networks through platforms for standardised data collection-the European Registries for Rare Endocrine Conditions (EuRRECa) model.
    Ali SR; Bryce J; Smythe C; Hytiris M; Priego AL; Appelman-Dijkstra NM; Ahmed SF
    Endocrine; 2021 Mar; 71(3):555-560. PubMed ID: 33512655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare Diseases in Europe: from a Wide to a Local Perspective.
    Baldovino S; Moliner AM; Taruscio D; Daina E; Roccatello D
    Isr Med Assoc J; 2016 Jun; 18(6):359-63. PubMed ID: 27468531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare neurological diseases: a Pandora's box for neurology (an European and Italian perspective).
    Federico A
    Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S12-7. PubMed ID: 23452765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CEMARA: a Web dynamic application within a N-tier architecture for rare diseases.
    Messiaen C; Le Mignot L; Rath A; Richard JB; Dufour E; Ben Said M; Jais JP; Verloes A; Le Merrer M; Bodemer C; Baujat G; Gerard-Blanluet M; Bourdon-Lanoy E; Salomon R; Ayme S; Landais P
    Stud Health Technol Inform; 2008; 136():51-6. PubMed ID: 18487707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The countdown for rare disease strategies is underway.
    Lancet Neurol; 2013 Jan; 12(1):1. PubMed ID: 23237886
    [No Abstract]   [Full Text] [Related]  

  • 15. Rare disease registries: an initiative to establish vasculitis registry in Poland.
    Padjas A; Sznajd J; Szczeklik W; Wójcik K; Wawrzycka K; Musiał J
    Pol Arch Med Wewn; 2014; 124(3):143-4. PubMed ID: 24569870
    [No Abstract]   [Full Text] [Related]  

  • 16. [European Reference Networks : Consequences for healthcare in Germany].
    Graessner H; Schäfer F; Scarpa M; Wagner TOF
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 May; 60(5):537-541. PubMed ID: 28275837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polish activity within Orphanet Europe--state of art of database and services.
    Jezela-Stanek A; Karczmarewicz D; Chrzanowska KH; Krajewska-Walasek M
    Dev Period Med; 2015; 19(4):536-41. PubMed ID: 26982769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare Diseases: Joining Mainstream Research and Treatment Based on Reliable Epidemiological Data.
    Groft SC; Posada de la Paz M
    Adv Exp Med Biol; 2017; 1031():3-21. PubMed ID: 29214563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The European Paediatric Rare Tumours Network - European Registry (PARTNER) project for very rare tumors in children.
    Orbach D; Ferrari A; Schneider DT; Reguerre Y; Godzinski J; Bien E; Stachowicz-Stencel T; Surun A; Almaraz RL; Dragomir M; Jani D; Ami TB; Roganovic J; Brecht IB; Ladenstein R; Bisogno G
    Pediatr Blood Cancer; 2021 Jun; 68 Suppl 4():e29072. PubMed ID: 33913610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Italian National Rare Diseases Registry.
    Taruscio D; Kodra Y; Ferrari G; Vittozzi L;
    Blood Transfus; 2014 Apr; 12 Suppl 3(Suppl 3):s606-13. PubMed ID: 24922301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.